zw191
·Code: ZW191
zw191: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Zymeworks Inc. (ZYME) | Phase 1 |
Clinical Trials (1)
A Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of a Folate Receptor Alpha Antibody Drug Conjugate, ZW191, in Participants With Advanced Solid Tumors
Frequently asked questions
Who is developing zw191?
zw191 is being developed by Zymeworks Inc..
How many clinical trials involve zw191?
BioSniper tracks 1 clinical trial involving zw191.
Get deeper analysis on zw191
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis